Literature DB >> 1852210

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6.

E Yonish-Rouach1, D Resnitzky, J Lotem, L Sachs, A Kimchi, M Oren.   

Abstract

Wild-type p53 protein has many properties consistent with its being the product of a tumour suppressor gene. Although the normal roles of tumour suppressor genes are still largely unknown, it seems that they could be involved in promoting cell differentiation as well as in mediating growth arrest by growth-inhibitory cytokines. Hence, the abrogation of wild-type p53 expression, which is a common feature of many tumours, could eliminate these activities. We have now tested this notion by restoring the expression of p53 in a murine myeloid leukaemic cell line that normally lacks p53. The use of a temperature-sensitive p53 mutant allowed us to analyse cells in which the introduced p53 had either wild-type or mutant properties. Although there seemed to be no effect on differentiation, the introduction of wild-type p53 resulted in rapid loss of cell viability in a way characteristic of apoptosis (programmed cell death). The effect of wild-type p53 was counteracted by interleukin-6. Thus products of tumour suppressor genes could be involved in restricting precursor cell populations by mediating apoptosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1852210     DOI: 10.1038/352345a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  444 in total

1.  p53-mediated apoptosis is attenuated in Werner syndrome cells.

Authors:  E A Spillare; A I Robles; X W Wang; J C Shen; C E Yu; G D Schellenberg; C C Harris
Journal:  Genes Dev       Date:  1999-06-01       Impact factor: 11.361

2.  Suppression or induction of apoptosis by opposing pathways downstream from calcium-activated calcineurin.

Authors:  J Lotem; R Kama; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

3.  The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53.

Authors:  C Gobert; A Skladanowski; A K Larsen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

4.  Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable.

Authors:  L McKendrick; D Milne; D Meek
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

5.  The involvement of p53 in dopamine-induced apoptosis of cerebellar granule neurons and leukemic cells overexpressing p53.

Authors:  D Daily; A Barzilai; D Offen; A Kamsler; E Melamed; I Ziv
Journal:  Cell Mol Neurobiol       Date:  1999-04       Impact factor: 5.046

Review 6.  Cell cycle checkpoints and their inactivation in human cancer.

Authors:  M Molinari
Journal:  Cell Prolif       Date:  2000-10       Impact factor: 6.831

7.  Microinjection technique used to study functional interaction between p53 and hepatitis B virus X gene in apoptosis.

Authors:  X W Wang
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

8.  Siah-1 binds and regulates the function of Numb.

Authors:  L Susini; B J Passer; N Amzallag-Elbaz; T Juven-Gershon; S Prieur; N Privat; M Tuynder; M C Gendron; A Israël; R Amson; M Oren; A Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 9.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

10.  Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.

Authors:  Gad Asher; Joseph Lotem; Leo Sachs; Chaim Kahana; Yosef Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.